Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:109886rdf:typepubmed:Citationlld:pubmed
pubmed-article:109886lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:109886lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:109886lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:109886lifeskim:mentionsumls-concept:C0006104lld:lifeskim
pubmed-article:109886lifeskim:mentionsumls-concept:C0033371lld:lifeskim
pubmed-article:109886lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:109886lifeskim:mentionsumls-concept:C0031977lld:lifeskim
pubmed-article:109886lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:109886lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:109886lifeskim:mentionsumls-concept:C0599682lld:lifeskim
pubmed-article:109886pubmed:issue3lld:pubmed
pubmed-article:109886pubmed:dateCreated1979-8-16lld:pubmed
pubmed-article:109886pubmed:abstractTextLevels of monoamine metabolites in three different regions of the rat brain were determined following treatment with piracetam (0.5 and 5 g/kg, i.p.). The concentration of prolactin in serum was also measured. Piracetam, at 5 g/kg, increased the levels of dihydroxyphenylacetic acid, homovanillic acid and 3-methoxy-4-hydroxyphenylethylene glycol, whereas 5-hydroxyindoleacetic acid was unaffected. The drug also increased prolactin concentrations in serum. The level of dopamine was unchanged in the olfactory tubercle and the striatum. These effects are different from those obtained with amphetamine-like drugs. The results would seem to indicate that piracetam accelerates brain catecholamine (CA) turnover via a blockade of CA receptors, as suggested for neuroleptic drugs. This effect could be responsible for the therapeutic action of piracetam on psychotic symptoms in psycho-organic disorders of old age. A blockade of brain CA receptors by piracetam is not compatible with facilitated learning, which seems to be mediated via other neuron systems than CA pathways.lld:pubmed
pubmed-article:109886pubmed:languageenglld:pubmed
pubmed-article:109886pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:109886pubmed:citationSubsetIMlld:pubmed
pubmed-article:109886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:109886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:109886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:109886pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:109886pubmed:statusMEDLINElld:pubmed
pubmed-article:109886pubmed:monthMarlld:pubmed
pubmed-article:109886pubmed:issn0033-3158lld:pubmed
pubmed-article:109886pubmed:authorpubmed-author:SkettPPlld:pubmed
pubmed-article:109886pubmed:authorpubmed-author:NybäckHHlld:pubmed
pubmed-article:109886pubmed:authorpubmed-author:WieselF AFAlld:pubmed
pubmed-article:109886pubmed:issnTypePrintlld:pubmed
pubmed-article:109886pubmed:day28lld:pubmed
pubmed-article:109886pubmed:volume61lld:pubmed
pubmed-article:109886pubmed:ownerNLMlld:pubmed
pubmed-article:109886pubmed:authorsCompleteYlld:pubmed
pubmed-article:109886pubmed:pagination235-8lld:pubmed
pubmed-article:109886pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:109886pubmed:meshHeadingpubmed-meshheading:109886-A...lld:pubmed
pubmed-article:109886pubmed:meshHeadingpubmed-meshheading:109886-P...lld:pubmed
pubmed-article:109886pubmed:meshHeadingpubmed-meshheading:109886-B...lld:pubmed
pubmed-article:109886pubmed:meshHeadingpubmed-meshheading:109886-R...lld:pubmed
pubmed-article:109886pubmed:meshHeadingpubmed-meshheading:109886-C...lld:pubmed
pubmed-article:109886pubmed:meshHeadingpubmed-meshheading:109886-M...lld:pubmed
pubmed-article:109886pubmed:meshHeadingpubmed-meshheading:109886-P...lld:pubmed
pubmed-article:109886pubmed:meshHeadingpubmed-meshheading:109886-O...lld:pubmed
pubmed-article:109886pubmed:meshHeadingpubmed-meshheading:109886-B...lld:pubmed
pubmed-article:109886pubmed:meshHeadingpubmed-meshheading:109886-P...lld:pubmed
pubmed-article:109886pubmed:year1979lld:pubmed
pubmed-article:109886pubmed:articleTitleEffects of piracetam on brain monoamine metabolism and serum prolactin levels in the rat.lld:pubmed
pubmed-article:109886pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:109886lld:pubmed